Events

E.g., 11/20/2025

  • Alcohol Associated Liver Disease (ALD-ALLY)

    Friday, April 10, 2026
    All day
    50 Haven Ave., New York, NY 10032 Main Lounge
    • Basic Health Sciences
    • Clinical Health Sciences
    • College of Physicians and Surgeons
    • Columbia Nursing
    • Education
    • Healthcare
    • Mailman School of Public Health
    • Research
    • Teaching and Learning
    Program Overview
 IN-PERSON & VIRTUAL CONFERENCE We’re excited to announce the 2nd annual ALD-ALLY (Alcohol-associated Liver Disease patients deserve ALcohol LiteracY) Conference, scheduled on April 10, 2026. This one-day CME conference is designed to meet the educational needs of healthcare professionals. It will facilitate intimate dialogues among experts, providers, and stakeholders, aiming to enhance collaboration, advocacy, research, and care delivery for patients with Alcohol-Associated Liver Disease (ALD). Our goal is to foster meaningful discussions that will advance the field of ALD and MetALD. The conference will kick off on Friday morning, with the exhibits open from breakfast until the conclusion of the evening reception.  A light reception will take place in the exhibit hall immediately following the last presentation. All breaks will be held in the exhibit hall to encourage attendee engagement and foot traffic throughout the space. ALD-ALLY is a call to action for advancing the science and care of patients with alcohol-associated liver disease (ALD) by gathering international experts to lead a multidisciplinary dialogue among a wide spectrum of stakeholders. Our intent is for ALD-ALLY to become the premier annual ALD meeting focused on actionable initiatives and collaborations through state-of-the-art lectures, academic debates, and patient advocacy in a lively in-person, discussion-encouraged setting. Be an ALLY and join us in New York!   Learning Objectives & Agenda Highlights Emerging Concepts and Therapies for MetALD Advances in Digital Care for ALD and MetALD Incorporating Genetics and Biomarkers in MASH, MetALD, and ALD Care High Impact Studies in AUD, ALD, and MetALD— Year in Review Innovations in Integrated Alcohol Care: Inpatient, Outpatient, and the Patient Voice Alcohol and MetALD Debates Video Access Following the program, all registrants will have access to lecture video recordings for ONE month. ACCME accredited program  www.ColumbiaMedicineCME.org

  • 3rd International Tremor Congress

    Thursday, April 30, 2026 to Friday, May 1, 2026
    All day
    Off-campus Tampa Marriott Water Street, Tampa, Florida
    • College of Physicians and Surgeons
    The meeting addresses an important need for a comprehensive, academic educational program providing the latest information on innovations, insights on the latest science, and translation of the science to patient care. The conference is also consistent with the national call of the Precision Medicine Initiative for health care providers to pursue new approaches that tailor treatment to the individual patient’s characteristics because patient response to conventional treatments for tremor is often variable; therefore, education on new surgical and medical advancements that account for individual differences can optimize outcomes for patients with tremor. In addition, to understand the heterogeneity of tremor disorders will help to design and conduct robust clinical trials to push forward therapy development. At the conclusion of this activity, participants will be better able to: • Formulate an evidence-based approach to optimize the treatment for tremor disorders. • Develop evidence-based scientific knowledge for the future clinical study design in tremor disorders. • Describe the up-do-date clinical diagnosis and treatment in each tremor disorder. • Indicate the cutting-edge scientific discovery for tremor and also current tremor therapy development.

  • IICD Seminar Series: Mona Singh, Princeton University

    Wednesday, May 13, 2026
    2:00 PM to 3:00 PM
    Hybrid Event Schermerhorn Hall 603
    • Research
    The Herbert and Florence Irving Institute for Cancer Dynamics will continue its seminar series on the topic of mathematical sciences underpinning cancer research. The monthly seminars take place on the second Wednesday of the month, 2:00-3:00 PM EST. The presentations are open to the Columbia community (in person and online) and to researchers outside Columbia (via Zoom). On Wednesday, May 13th (2:00 PM ET), IICD welcomes Dr. Mona Singh from Princeton University. Seminar hosted by Dr. Simon Tavaré. The seminar will take place in person in Schermerhorn Hall 603 (Morningside Heights campus). If you wish to attend the seminar remotely, please register using the following link: https://columbiauniversity.zoom.us/meeting/register/C1HyFH4YR4aZiC7usFGnVA Title: TBA Abstract: TBA Bio: Mona Singh is a professor of computer science and the Lewis Sigler Institute for Integrative Genomics. She is also affiliated with the Department of Molecular Biology and the Omenn-Darling Bioengineering Institute.  Her group works broadly in computational molecular biology, as well as its interface with machine learning and algorithms. She has been on the faculty at Princeton University since 1999. She received her A.B. and S.M. degrees from Harvard University and her Ph.D. from MIT, all in computer science. Among her awards are the Presidential Early Career Award for Scientists and Engineers (PECASE) and the Rheinstein Junior Faculty Award from Princeton’s School of Engineering and Applied Science. She was named a Fellow of the ACM in 2019, and of the ISCB in 2018. If you would like to meet one-on-one (possibly via Zoom) or attend the lunch or dinner with the speaker, please contact the event organizer.

  • Hematological Malignancies Seminar Series: Christopher Mason, PhD

    Tuesday, May 26, 2026
    1:15 PM to 2:15 PM
    Herbert Irving Comprehensive Cancer Center, 1130 St. Nicholas Ave., New York, NY 10032 1st Floor Auditorium
    • Basic Health Sciences
    • Clinical Health Sciences
    • College of Physicians and Surgeons
    Speaker: Christopher Mason, PhD, Professor of Physiology and Biophysics, Director WorldQuant Initiative for Quantitative Prediction and WorldQuant Foundation Research Scholar, Professor of Computational Biomedicine in the Institute of Computational Biomedicine, Professor of Neuroscience in the Brain and Mind Institute, Weill Cornell Medicine Hosted by Aaron Viny, MD, Assistant Professor of Medicine at CUIMC. This event is sponsored by the Herbert Irving Comprehensive Cancer Center's (HICCC) Edward P. Evans Center for Myelodysplastic Syndromes (MDS) at Columbia University, established to foster an all-encompassing approach in studying MDS giving us molecular, cellular genetic and epigenetic insights to develop and test innovative therapies.

  • 8th Annual Columbia University Endoscopic Otolaryngology Course

    Wednesday, June 3, 2026 to Friday, June 5, 2026
    All day
    Roy And Diana Vagelos Education Center, 104 Haven Ave., New York, NY 10032
    • College of Physicians and Surgeons
    This exciting course will introduce cutting-edge surgical techniques and the latest advances in patient care, including transcanal endoscopic ear surgery, transnasal Eustachian tube surgery, and advances in endoscopic sinus and skull base surgery. This course is also the first of its kind to feature dedicated endoscopic orbital surgery instruction!

  • Neurogenetics: Advances in Neurotherapeutics and Diagnostics

    Friday, June 5, 2026
    All day
    The New York Academy of Sciences, 7 World Trade Center, 250 Greenwich St., 40th Floor, New York, NY 10007
    • College of Physicians and Surgeons
    TBD

  • Hematological Malignancies Seminar Series: Saar Gill, MD, PhD

    Tuesday, June 23, 2026
    1:15 PM to 2:15 PM
    Herbert Irving Comprehensive Cancer Center, 1130 St. Nicholas Ave., New York, NY 10032 1st Floor Auditorium
    • Basic Health Sciences
    • Clinical Health Sciences
    • College of Physicians and Surgeons
    Speaker: Saar Gill, MD, PhD, Associate Professor of Medicine in the Division of Hematology-Oncology, University of Pennsylvania, Perelman School of Medicine Hosted by Stavroula Kousteni, PhD, Professor, Department of Physiology & Cellular Biophysics; Director, Evans MDS Center at Columbia. This event is sponsored by the Herbert Irving Comprehensive Cancer Center's (HICCC) Edward P. Evans Center for Myelodysplastic Syndromes (MDS) at Columbia University, established to foster an all-encompassing approach in studying MDS giving us molecular, cellular genetic and epigenetic insights to develop and test innovative therapies.

  • 49th Annual Columbia Renal Biopsy Course

    Wednesday, July 15, 2026 to Friday, July 17, 2026
    All day
    College of Physicians and Surgeons, 630 W. 168 St., New York, NY 10032 Faculty Club, 4th Floor
    • Clinical Health Sciences
    • College of Physicians and Surgeons
    • Columbia Nursing
    • Education
    • Mailman School of Public Health
    • Natural Sciences
    • Other
    • Research
    • Teaching and Learning
    PROGRAM DESCRIPTION AND OBJECTIVES The course is designed to assist nephrologists and renal pathologists (including nephrology and renal pathology trainees) in diagnosing and managing the most common forms of medical renal disease, including diseases that target the glomerulus, tubules, interstitium, and blood vessels. The activity will span three days and include lectures covering the following content areas: Nephrotic syndrome, Nephritic syndrome, Genetics, Tubulointerstitial, Vascular Disease, Transplant & Dysproteinemia. These lectures will be delivered live in front of an audience but also streamed simultaneously for virtual participants; all participants will have access to these lectures for 3 months after the conference. Upon completion of this activity, participants will be better able to:  • Identify the role of complement in the pathophysiology of glomerular diseases and how novel complement-targeting therapies can fit into treatment patterns. • Enhance diagnostic suspicion for a genetically mediated form of glomerular disease and facilitate rapid referral for genetic testing. • Assess which patients would benefit from repeat biopsies in the management of their glomerular diseases.

Pages